| 乳酸-羟基乙酸共聚物微球的研究进展 |
| |
| 引用本文： | 魏利军. 特殊注射剂的发展现状与市场概况[J]. 药学进展, 2018, 42(12): 913-921. |
| |
| 作者姓名： | 魏利军 |
| |
| 作者单位： | 1.舒泰神生物制药股份有限公司，北京 100176 |
| |
| 摘 要： | 特殊注射剂是一类复杂的载药系统，如脂质体、微球和注射混悬剂等，尽管上市的产品不多，但经济价值巨大，部分产品的市场表现甚至超过了新分子实体。分别对全球范围内已上市的注射脂质体、注射微球和注射混悬剂作简要介绍，从技术特征、市场效应和临床需求3个方面，介绍这3种特殊注射剂的发展现状和发展潜力。
|
| 关 键 词： | 注射剂 微球 脂质体 混悬剂 市场 |
The liposomal formulation of doxorubicin |
| |
| WEI Lijun. Current Status and Market Overview of Special Injections[J]. Progress in Pharmaceutical Sciences, 2018, 42(12): 913-921. |
| |
| Authors: | WEI Lijun |
| |
| Affiliation: | 1.Staidson Biopharmaceutical Inc., Beijing 100176, China |
| |
| Abstract: | Special injections are complex drug delivery systems such as injectable microspheres, liposomes and suspensions, which hold great market potential despite a limited number of approvals. Certain products even show better market performance than new molecular entities. This review briefly describes globally launched special injections, including injectable liposomes, injectable microspheres and injectable suspensions. The current status and development potential of these three types of complex injections were discussed from the three aspects of technical profiles, market effects and clinical needs. |
| |
| Keywords: | injection microsphere liposome suspension market |
|
| 点击此处可从《药学进展》浏览原始摘要信息 |
|
点击此处可从《药学进展》下载全文 |
